Moderna (MRNA) Inventory Average (2021 - 2026)

Moderna (MRNA) has 6 years of Inventory Average data on file, last reported at $149.5 million in Q1 2026.

• On a quarterly basis, Inventory Average rose 22.04% year-over-year to $149.5 million in Q1 2026; TTM through Mar 2026 was $149.5 million, a 22.04% increase from a year earlier, with the FY2025 full-year figure at $135.0 million, down 15.36% from the prior year.
• Inventory Average for Q1 2026 stood at $149.5 million, down from $242.5 million in the prior quarter.
• Over the last five years, Inventory Average for MRNA reached as high as $2.0 billion in Q3 2022 and fell as low as $122.5 million in Q1 2025.
• Historically, Inventory Average has averaged $699.7 million across 5 years, with a median of $347.0 million in 2024.
• Across the five-year window, Inventory Average jumped 525.32% in 2022 and sank 77.23% in 2023, its largest moves.
• Year by year, Inventory Average stood at $1.5 billion in 2022, then sank by 77.23% to $344.5 million in 2023, then slipped by 23.22% to $264.5 million in 2024, then dropped by 8.32% to $242.5 million in 2025, then slumped by 38.35% to $149.5 million in 2026.
• Per Business Quant data, the three most recent Inventory Average figures were $149.5 million in Q1 2026, $242.5 million in Q4 2025, and $286.0 million in Q3 2025.